Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation-Reference-Cited by-同舟云学术

Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation

Published:2022-11 Issue: Volume:103 Page:138-146
ISSN:1120-1797
Container-title:Physica Medica
language:en
Short-container-title:Physica Medica

Author:

Paquier Zelda,Chao Shih-Li,Bregni Giacomo,Sanchez Ana Veron,Guiot Thomas,Dhont Jennifer,Gulyban Akos,Levillain Hugo,Sclafani Francesco,Reynaert Nick,Bali Maria Antonietta

Publisher

Elsevier BV

Subject

General Physics and Astronomy,Radiology, Nuclear Medicine and imaging,General Medicine,Biophysics

Reference53 articles.

1. Clinical applications of diffusion weighted imaging in neuroradiology;Drake-Pérez;Insights Imaging,2018

2. PI-RADS prostate imaging – reporting and data system: 2015, Version 2;Weinreb;Eur Urol,2016

3. Diffusion-weighted magnetic resonance imaging: what makes water run fast or slow?;Fornasa;J Clin Imaging Sci,2011

4. Diffusion-weighted MRI in the body: applications and challenges in oncology;Koh;Am J Roentgenol,2007

5. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations;Padhani;Neoplasia,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing intra‐ and inter‐institution variability of a radiomic framework based on Apparent Diffusion Coefficient in prostate cancer;Medical Physics;2024-08-22

2. Towards quantitative MRI for the clinic;Physica Medica;2024-08

3. Phantoms for Quantitative Body MRI: a review and discussion of the phantom value;Magnetic Resonance Materials in Physics, Biology and Medicine;2024-06-19

4. Whole Process of Standardization of Diffusion-Weighted Imaging: Phantom Validation and Clinical Application According to the QIBA Profile;Diagnostics;2024-03-09

5. Advancing noninvasive glioma classification with diffusion radiomics: Exploring the impact of signal intensity normalization;Neuro-Oncology Advances;2024-01-01